Literature DB >> 32198079

Improved monitoring of adherence with patching treatment using a microsensor and Eye Patch Assistant.

Jingyun Wang1, Hongxin Xu2, Bryan De La Cruz3, Sarah E Morale3, Reed M Jost3, David A Leske4, Jonathan M Holmes4, Eileen E Birch3.   

Abstract

BACKGROUND: Use of a microsensor has been suggested to monitor patching adherence. Application has been limited because the microsensor's small size makes it easy to lose and a swallowing risk. We designed the Eye Patch Assistant (EPA) to hold the small microsensor in place and reduce the risk of loss or swallowing. This study reports the accuracy, precision, ease of use, and comfort for patching with EPA (patch+EPA) to monitor adherence.
METHODS: Adults (N = 13) wore an adhesive patch alone or a patch+EPA for 2 hours each, recorded wear time, and completed an ease of use/comfort questionnaire; 30 children wore a patch or patch+EPA and completed the questionnaire. Sensor sampling interval was every 5 minutes or every 1 minute. Sensor accuracy and precision were evaluated by Bland-Altman analysis and 95% limits of agreement, and questionnaire scores compared by Wilcoxon tests.
RESULTS: With 5-minute sampling, we found excellent accuracy for adults (mean actual vs recorded time difference, 1.4 minutes) and children (mean difference, -0.9 min). We found high precision for both adults and children (95% limits of agreement half widths of 6.4 minutes and 1.9 minutes, respectively). In adults, the ease of use score for the patch+EPA was lower than the patch (P < 0.01), but the comfort score for the patch+EPA was higher (P < 0.01). For children, scores did not differ significantly. The patch+EPA functioned well between 45° and 82°F.
CONCLUSIONS: The patch+EPA was well accepted and monitored adherence accurately and precisely.
Copyright © 2020 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32198079      PMCID: PMC7276289          DOI: 10.1016/j.jaapos.2020.01.006

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  19 in total

1.  A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children.

Authors:  David K Wallace; Allison R Edwards; Susan A Cotter; Roy W Beck; Robert W Arnold; William F Astle; Carmen N Barnhardt; Eileen E Birch; Sean P Donahue; Donald F Everett; Joost Felius; Jonathan M Holmes; Raymond T Kraker; Michele Melia; Michael X Repka; Nicholas A Sala; David I Silbert; Katherine K Weise
Journal:  Ophthalmology       Date:  2006-06       Impact factor: 12.079

2.  Electronic recording of occlusion treatment for amblyopia: potential of the new technology.

Authors:  Yaroslava Chopovska; Sjoukje E Loudon; Licia Cirina; Alina Zubcov; Huibert J Simonsz; Marc Lüchtenberg; Maria Fronius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

3.  Limitations of the TheraMon® -microsensor in monitoring occlusion therapy.

Authors:  Charlotte Schramm; Annegret Abaza; Gunnar Blumenstock; Till E Bechtold; Annekatrin Rickmann; Karl-Ulrich Bartz-Schmidt; Dorothea Besch; Kai Januschowski
Journal:  Acta Ophthalmol       Date:  2016-06-27       Impact factor: 3.761

4.  An educational intervention to improve adherence to high-dosage patching regimen for amblyopia: a randomised controlled trial.

Authors:  Archana Pradeep; Frank Antony Proudlock; Musarat Awan; Glen Bush; Jacqueline Collier; Irene Gottlob
Journal:  Br J Ophthalmol       Date:  2014-07       Impact factor: 4.638

5.  Compliance in amblyopia therapy: objective monitoring of occlusion.

Authors:  A R Fielder; M Irwin; R Auld; K D Cocker; H S Jones; M J Moseley
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

6.  Compliance with occlusion therapy for childhood amblyopia.

Authors:  Michael P Wallace; Catherine E Stewart; Merrick J Moseley; David A Stephens; Alistair R Fielder
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-17       Impact factor: 4.799

7.  Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.

Authors:  Michael X Repka; Raymond T Kraker; Jonathan M Holmes; Allison I Summers; Stephen R Glaser; Carmen N Barnhardt; David R Tien
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

8.  A randomized trial of patching regimens for treatment of moderate amblyopia in children.

Authors:  Michael X Repka; Roy W Beck; Jonathan M Holmes; Eileen E Birch; Danielle L Chandler; Susan A Cotter; Richard W Hertle; Raymond T Kraker; Pamela S Moke; Graham E Quinn; Mitchell M Scheiman
Journal:  Arch Ophthalmol       Date:  2003-05

Review 9.  Occlusion dose monitoring in amblyopia therapy: status, insights, and future directions.

Authors:  Catherine E Stewart; Merrick J Moseley; Pantelis Georgiou; Alistair R Fielder
Journal:  J AAPOS       Date:  2017-09-07       Impact factor: 1.220

10.  Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).

Authors:  Catherine E Stewart; Merrick J Moseley; David A Stephens; Alistair R Fielder
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-09       Impact factor: 4.799

View more
  1 in total

1.  Randomized clinical trial of streaming dichoptic movies versus patching for treatment of amblyopia in children aged 3 to 7 years.

Authors:  Reed M Jost; Lindsey A Hudgins; Lori M Dao; David R Stager; Becky Luu; Cynthia L Beauchamp; Jeffrey S Hunter; Prashanthi Giridhar; Yi-Zhong Wang; Eileen E Birch
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.